Redenlab contributes to position paper on advancing digital healthtechnologies for frontotemporal degeneration
MEDIA RELEASE MELBOURNE, VIC – A major collaborative paper published in Alzheimer’s & Dementia introduces a critical roadmap…
clinical trial
Latest content
Redenlab announces landmark study in collaboration with Queensland Institute of Medical Research
Redenlab announces landmark study in collaboration with Queensland Institute of Medical Research
Redenlab’s Chief Science Officer, Adam P. Vogel, PhD, leads groundbreaking study on speech analysis for neurodegenerative diseases
MEDIA RELEASE Melbourne, 19 January 2024 — Redenlab, a leader in innovative healthcare solutions, ispleased to announce a…
